Edwards Lifesciences (EW) Minority Interest (2023 - 2025)

Edwards Lifesciences has reported Minority Interest for 3 years, with the latest figure at $61.2 million in Q2 2025.

• For the quarter ending Q2 2025, Minority Interest fell 8.93% year-over-year to $61.2 million; the trailing twelve-month figure through Jun 2025 stood at $61.2 million (down 8.93% YoY), and the FY2024 full-year result was $64.5 million, down 7.06% from the prior year.
• Minority Interest for Q2 2025 stood at $61.2 million, down from $62.9 million in the prior quarter.
• The five-year high for Minority Interest was $84.0 million in Q1 2023, with the low at $61.2 million in Q2 2025.
• Average Minority Interest over 3 years is $68.4 million, with a median of $67.8 million recorded in 2024.
• Peak annual rise in Minority Interest reached 5.08% in 2024, while the deepest fall reached 18.45% in 2024.
• Tracing EW's Minority Interest over 3 years: stood at $69.4 million in 2023, then dropped by 7.06% to $64.5 million in 2024, then declined by 5.12% to $61.2 million in 2025.
• The last three Minority Interest figures came in at $61.2 million (Q2 2025), $62.9 million (Q1 2025), and $64.5 million (Q4 2024), per Business Quant data.

Peer Comparison